EVair 03 (Jun-air) air compressor, model numbers: 1609000 and 1609002
Publicado el 7 de febrero de 2024 · Inicio del retiro: 29 de diciembre de 2023
Resumen
FDA registra el retiro Z-0775-2024 de dispositivos médicos de Clase I, publicado el 7 de febrero de 2024 e iniciado el 29 de diciembre de 2023. Empresa responsable: Datex-Ohmeda, Inc.; Estado: En curso; Cantidad reportada: 12 units; Lote: UDI/DI ********, Serial Numbers: CBCS01269, CBCT02328, CBCT03050, CBCT02306, CBCT02301, CBCT02303, CBCT02302, CBCT02088, CBCT02309, CBCT02304, CBCU00717, CBCU00559. La Clase I indica una probabilidad razonable de consecuencias graves para la salud o muerte.
Estado reportado al momento de publicación: Ongoing — openFDA actualiza semanalmente y este campo no refleja el estado más reciente. Confirma siempre con la fuente oficial.
Qué peligro representa
GE HealthCare has become aware of elevated levels of formaldehyde when the EVair or EVair 03 (Jun-Air) optional compressors are used with the CARESCAPE R860 or Engstr®m Carestation/Pro ventilators, respectively. These elevated results were observed in preliminary testing that was conducted at an elevated room temperature of 40oC (104oF), at the lowest possible flow condition of 2 L/min (worstcase, minimum bias flow with no additional ventilation), and all of the gas being supplied from the compressor (i.e., FiO2 of 21% / no supplemental oxygen). GE HealthCare is continuing to evaluate the root cause for these elevated levels of formaldehyde. While these test conditions are not representative of typical clinical use conditions,GE HealthCare is taking this action to further reduce the potential for patient exposure.
Qué hacer
Voluntary: Firm initiated · Letter
Recibe un correo cuando FDA publique un retiro como este
Gratis. Solo te escribimos cuando hay un retiro nuevo que coincide. Te das de baja con un clic.
Detalles del retiro
- Fabricante
- Datex-Ohmeda, Inc.
- Distribuidor
- Worldwide
- Lote
- UDI/DI ********, Serial Numbers: CBCS01269, CBCT02328, CBCT03050, CBCT02306, CBCT02301, CBCT02303, CBCT02302, CBCT02088, CBCT02309, CBCT02304, CBCU00717, CBCU00559
- Clasificación de riesgo
- Class I
- Área (FDA)
- device
- País
- United States
Retiros relacionados
- FDAEt Control, Software option for anesthesia gas machine to achieve and maintain targeted end tidal oxygen and23 de septiembre de 2026
- FDAAisys CS2 with Et Control, Datex-Ohmeda anesthesia system, Part Number 1011-9000-00023 de septiembre de 2026
- FDAAisys, Datex-Ohmeda anesthesia system, Part Number 1011-9050-00023 de septiembre de 2026
- FDAAisys CS2, Datex-Ohmeda anesthesia system, Part Number 1011-9055-00023 de septiembre de 2026
- FDAEVair air compressor, model numbers: M1230849 and M12308477 de febrero de 2024
- FDAEvAir CPRSR Kit Upgrade: a) DISS/CEE 7/7 230V 50/60 HZ, Model Number M1230849; b) DISS/NEMA 5-15 115V 60 HZ,7 de febrero de 2024
Preguntas sobre este retiro
¿EVair 03 (Jun-air) air compressor, model numbers: 1609000 and 1609002 fue retirado del mercado?
Sí. FDA publicó el retiro Z-0775-2024 el 7 de febrero de 2024. Peligro reportado: GE HealthCare has become aware of elevated levels of formaldehyde when the EVair or EVair 03 (Jun-Air) optional compressors are used with the CARESCAPE R860 or Engstr®m Carestation/Pro ventilators, respectively. These elevated results were observed in preliminary testing that was conducted at an elevated room temperature of 40oC (104oF), at the lowest possible flow condition of 2 L/min (worstcase, minimum bias flow with no additional ventilation), and all of the gas being supplied from the compressor (i.e., FiO2 of 21% / no supplemental oxygen). GE HealthCare is continuing to evaluate the root cause for these elevated levels of formaldehyde. While these test conditions are not representative of typical clinical use conditions,GE HealthCare is taking this action to further reduce the potential for patient exposure.
¿Qué debo hacer si tengo este producto?
Voluntary: Firm initiated · Letter